Carcinoma, Large Cell
Information
- Disease name
- Carcinoma, Large Cell
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT01317615 | Completed | Phase 4 | RAD001 With Paclitaxel and Carboplatin in First Line Treatment of Patients With Advanced Large Cell Lung Cancer With Neuroendocrine Differentiation | April 2011 | March 2015 |
| NCT02151149 | Completed | Phase 4 | Safety and Efficacy Study of Abraxane in Combination With Carboplatin to Treat Advanced NSCL Cancer in the Elderly | June 9, 2014 | July 14, 2017 |
| NCT00673049 | Terminated | Phase 3 | Trial Of CP-751, 871 And Erlotinib In Refractory Lung Cancer | May 2008 | April 2012 |
| NCT00596830 | Terminated | Phase 3 | Carboplatin And Paclitaxel With Or Without CP-751, 871 (An IGF-1R Inhibitor) For Advanced NSCLC Of Squamous, Large Cell And Adenosquamous Carcinoma Histology | April 2008 | September 2012 |
| NCT01441128 | Terminated | Phase 1 | -02341066 and PF-00299804 for Advanced Non-Small Cell Lung Cancer | September 1, 2011 | February 26, 2015 |
| NCT00632203 | Terminated | Phase 2 | Study of Maintenance Temozolomide Versus Observation in Stable or Responding Stage III/IV Non-Small Cell Lung Cancer Patients (Study P05146) | March 4, 2008 | January 7, 2011 |
| NCT01497041 | Unknown status | Phase 2 | A Phase II Clinical Trial of Docetaxel, Oxaliplatin Combination Chemotherapy in Patients With Stage IIIB/IV Non-adenocarcinoma, Non-small Cell Lung Cancer (NSCLC) as Second-line Treatment | February 2011 | December 2013 |
- MeSH unique ID (MeSH (Medical Subject Headings))
- D018287